Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
Clinical trial NCT05660980 · RECRUITING
Trial details
- NCT number
- NCT05660980
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2026-10-22
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.